Paradigm

Paradigm is a New York City company that operates a technology platform focused on clinical trials[1]. The company was founded in 2022 by Jonathan Hirsch and Kent Thoelke[1]. According to company records, Paradigm's domain is paradigm.xyz and it was established in 2018[2]. The platform is designed to expand patient participation in clinical trials and improve trial efficiency[1].

Funding

• Series B, $78M

  with ARCH Venture Partners, BrightEdge Fund, DFJ Growth, F-Prime, General Catalyst, Google Ventures, Lux Capital, Mubadala Capital

In the news

• Nous Research's NousCoder-14B is an open-source coding model landing right in the Claude Code momentVentureBeat AI · Jan 7, 2026

Backers

• FARCH Venture Partners
• FBrightEdge Fund
• FDFJ Growth
• FF-Prime
• General Catalyst

  Global venture capital and investment firm with a New York office

• FGoogle Ventures
• Lux Capital

  New York and Silicon Valley venture firm investing in counter-conventional science and technology companies

• Lux Capital

  A venture capital firm that invests in emerging science and technology companies.

• FMubadala Capital

Something wrong or missing? Send a correction. Fixed within 24 hours.